http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3743067-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
filingDate 2019-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bea1034779cc465540dadaad7ddaa2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c27b6b8ac2b44c2f4d92ba08b105d4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1815f4cc041eaa4b9f0d397d38fb060b
publicationDate 2020-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3743067-A1
titleOfInvention Combination treatment of acute myeloid leukemia
abstract The present invention relates to the use of volasertib, or a pharmaceutically acceptable salt thereof or a hydrate thereof, in combination with a BET inhibitor, or a pharmaceutically acceptable salt thereof or a hydrate thereof for treating patients suffering from acute myeloid leukemia (AML).
priorityDate 2018-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1050
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14609
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23422317
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A287AGZ2
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID423901
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403869
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID840
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID444984
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226672788
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9Y6K1
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID739139
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID42008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22103330
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393439
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1MD58
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7670
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30590
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226672789
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID359716
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281542
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID22059
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID28984
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE2R027
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100379269
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID421991
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64026
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24252
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1788
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100766857
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25498
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID171023
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ4W5Z4
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID450745
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12606
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID214133
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397276
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF7E6A3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43514
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7157
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395476
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396200
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID54790
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID526279
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID408016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7504
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12369
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1PCB1
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24842
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID816477
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID455214
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12367
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID66214
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID836
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID266985
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4869
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1001
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403066
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID461669
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13435
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100689061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393851
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID427549
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25402
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18148
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO88508
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID140815
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1LZ53

Total number of triples: 99.